13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 38 holding rows worth $227,749,000.
- Accession
- 0001420506-20-000263
- Filer
- CIK 1617201
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 38 entries on the cover page, a total value of $227,749,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $227,749,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 130,000 | $19,458,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 237,500 | $17,019,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 328,129 | $14,904,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,036,000 | $14,245,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 161,195 | $14,198,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 62,900 | $12,859,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 388,600 | $10,756,000 | thousands by filing date | |
| AC IMMUNE SA | H00263105 | SHS | 1,242,843 | $10,589,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 517,844 | $10,367,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 450,326 | $8,989,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 142,800 | $8,978,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 1,428,277 | $8,298,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 92,737 | $7,841,000 | thousands by filing date | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 217,686 | $7,264,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047907 | CALL | 142,400 | $6,468,000 | thousands by filing date | call |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 247,178 | $6,283,000 | thousands by filing date | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 165,000 | $4,891,000 | thousands by filing date | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 406,673 | $4,433,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 234,823 | $3,816,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 224,702 | $3,566,000 | thousands by filing date | |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 617,836 | $2,972,000 | thousands by filing date | |
| EVOLUS INC | 30052C107 | COM | 236,939 | $2,884,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 391,894 | $2,669,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 1,258,224 | $2,630,000 | thousands by filing date | |
| R1 RCM INC | 749397105 | COM | 200,000 | $2,596,000 | thousands by filing date | |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 279,390 | $2,528,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 11,293 | $2,309,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 160,883 | $2,250,000 | thousands by filing date | |
| CUE BIOPHARMA INC | 22978P106 | COM | 137,628 | $2,185,000 | thousands by filing date | |
| ALLAKOS INC | 01671P950 | PUT | 20,700 | $1,974,000 | thousands by filing date | put |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 450,000 | $1,814,000 | thousands by filing date | |
| TRINET GROUP INC COM | 896288107 | Stock | 28,104 | $1,591,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 320,000 | $1,283,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960W104 | COM | 1,484,527 | $632,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. | 05464T954 | PUT | 6,000 | $620,000 | thousands by filing date | put |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 38,481 | $616,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 8,100 | $520,000 | thousands by filing date | |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 159,336 | $454,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-20-000263 | this filing | 2020-02-14 | acceptance time not in the bulk data set |